Ultragenyx Pharmaceutical Inc - Company Profile
Powered by 
All the data and insights you need on Ultragenyx Pharmaceutical Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ultragenyx Pharmaceutical Inc Strategy Report
- Understand Ultragenyx Pharmaceutical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Ultragenyx Pharmaceutical Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Ultragenyx Pharmaceutical Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 20 Sep 2018 | Lorem |
| Ultragenyx’s Phase I/II gene therapy OTC deficiency trial has experts question ureagenesis increase relevance in less-severe patients | 23 Jul 2018 | Jennifer C. Smith-Parker |
| Ultragenyx faces dicey proposition for FDA filing sans Phase III LC-FAOD trial for triheptanoin but potential allowance based on orphan status, Phase II data, experts say | 23 Apr 2018 | Jennifer C. Smith-Parker |
| Ultragenyx’s Crysvita has lifelong XLH treatment potential post bone solid FDA approval, experts say | 16 Mar 2018 | Jennifer C. Smith-Parker |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer